Transcriptomics Technologies Market Analysis | Coherent Market Insights

1
Coherent Market InsightS

• Market Research and Business Consulting
  Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
Transcriptomics Technologies Market Analysis
(2020-2027)

• Transcriptome refers to a set of all the
  transcripts present in an individual or a
  population of cells. Transcripts comprise all
  types of ribonucleic acid (RNA) molecules namely,
  messenger RNA (mRNA), ribosomal RNA (rRNA),
  transfer RNA (tRNA), and other non-coding RNA
  molecules.
• Statistics
• The global transcriptomics technologies market is
  estimated to account for US 15,569.1 Mn in terms
  of value by the end of 2027.

3
Global Transcriptomics Technologies Market
Drivers

• Approval and launch of microarrays is expected to
  propel growth of the global transcriptomics
  technologies market over the forecast period. For
  instance, in March 2020, Agilent Technologies
  Inc. launched Agilent GenetiSure Cyto microarrays
  for prenatal and postnatal research.
• Moreover, initiatives to advance personalized
  medicine are also expected to aid in growth of
  the market. For instance, in April 2020,
  Indivumed GmbH, an oncology company, launched the
  Oncology Alliance for Individualized Medicine, an
  international collaborative alliance to advance
  personalized medicine in cancer through
  IndivuType, the companys multi-omics database.

4
s

• Statistics
• North America held dominant position in the
  global transcriptomics technologies market in
  2019, accounting for 39.2 share in terms of
  value, followed by Europe and Asia Pacific,
  respectively.

5
Figure 1 Global Transcriptomics Technologies
Market Share () Value, By Region, 2019
6
Global Transcriptomics Technologies Market
Restraints

• Lack of efficient data analysis tools is expected
  to hinder growth of the market. With increasing
  technological advances, there has been a rising
  concern about data complexity post analysis of
  transcripts through sequencing platforms. Complex
  data management is one of the major limitations
  faced in transcriptome research. The data
  complexity increases with advances in the
  subsequent RNA analysis methodologies.
• Moreover, complex processes involved in isolation
  of RNA from the tissue of interest are also
  expected to limit the market growth.

7
(No Transcript)
8
Global Transcriptomics Technologies Market
Opportunities

• Increasing prevalence of cancer is expected to
  offer lucrative growth opportunities for players
  in the global transcriptomics technologies
  market. For instance, according to the American
  Cancer Society, in 2019, there will be an
  estimated 1,762,450 new cancer cases diagnosed
  and 606,880 cancer deaths in the U.S.
• Moreover, development of new technologies is also
  expected to aid in growth of the market. For
  instance, in December 2019, PathogenDx, Inc. was
  awarded two US Patents for Tandem PCR
  Microarray Hybridisation technology.

9
s

• Statistics
• The global transcriptomics technologies market
  was valued at US 4,625.8 Mn  in 2019 and is
  forecast to reach a value of US 15,569.1 Mn by
  2027 at a CAGR of 16.4 between 2020 and 2027.

10
Figure 2 Global Transcriptomics Technologies
Market Value (US Mn), 2016 2027
11

• . Market players are focusing on various
  inorganic strategies such as mergers and
  agreements. For instance, in December 2018, Nicox
  SA entered an exclusive license agreement with
  Ocumension Therapeutics for the development and
  commercialization of NCX 470, an ophthalmic
  solution, in China, Hong Kong, Macau, and Taiwan.

12
Figure 2. Global Glaucoma Eye Drops Market Value
(US Mn) Y-o-Y Growth (), 2017-2027
13
Market Trends/Key Takeaways

• Major players in the market are focused on
  launching new products to expand their product
  portfolio. For instance, in May 2019, Siemens
  Healthineers launched its new Atellica CH
  Enzymatic Hemoglobin A1c Assay to for diagnosing
  and monitoring diabetes.
• Major players in the market are also focused on
  adopting MA strategies to expand their product
  portfolio. For instance, in April 2020, Bio-Rad
  Laboratories, Inc. acquired Celsee, Inc., a
  developer of instruments and consumables for the
  isolation, detection, and analysis of single
  cells.

14
Global Transcriptomics Technologies Market
Competitive Landscape

• Major players operating in the global
  transcriptomics technologies market include,
  Affymetrix, Inc., Agilent Technologies, Inc.,
  Bio-Rad Laboratories, Inc., Danaher Corporation,
  Illumina, Inc., F. Hoffmann-La Roche Ltd., Life
  Technologies Corporation, LC Sciences, LLC, and
  Qiagen N.V.

15
Global Transcriptomics Technologies Market Key
Developments

• Major players in the market are focused on
  adopting partnership strategies to expand their
  product portfolio. For instance, in March 2020,
  Illumina, Inc. partnered with IDbyDNA Inc., a
  metagenomics technology company, for RD of
  next-generation sequencing-based workflows.
• Major players in the market are focused on
  approval and launch of new products to expand
  their product portfolio. For instance, in June
  2018, Agilent Technologies Inc. received the U.S.
  Food and Drug Administration (FDA) approval for
  its Dako PD-L1 IHC 22C3 pharmDx assay used for
  determining PD-L1 expression in cervical cancer.

16

• Request sample copy here
• Request Customization here
• Talk to Analyst
• Buy Now
• Reference
• https//www.coherentmarketinsights.com/market-insi
  ght/transcriptomics-technologies-market-3989

17
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

18
Contact Us   

• Mr. Shah
• Coherent Market Insights Pvt. Ltd.
• Address 1001 4th ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

19
Thank You!

• Kindly follow CMI Social Media Profiles for the
  latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/